» Articles » PMID: 32006215

Astrocyte Diversity: Current Insights and Future Directions

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2020 Feb 2
PMID 32006215
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes make up 20-40% of glial cells within the central nervous system (CNS) and provide several crucial functions, ranging from metabolic and structural support to regulation of synaptogenesis and synaptic transmission. Although these cells are morphologically and functionally complex, astrocytes have been historically regarded as homogenous cell populations and studied as one population of cells. Fortunately, recent evidence in RNA profiling and imaging data has begun to refute this view. These studies suggest heterogeneity of astrocytes across brain regions, differing in many aspects such as morphology, function, physiological properties, developmental origins, and response to disease. Increased understanding of astrocyte heterogeneity is critical for investigations into the function of astrocytes in the brain and neuro-glia interactions. Furthermore, insights into astrocyte heterogeneity can help better understand their role in neurological disorders and potentially produce novel approaches to treating these diseases.

Citing Articles

New perspectives on heterogeneity in astrocyte reactivity in neuroinflammation.

Santos D, Silva Lima S, Moreira L, Costa S, de Sampaio Schitine C Brain Behav Immun Health. 2025; 44:100948.

PMID: 40028234 PMC: 11871470. DOI: 10.1016/j.bbih.2025.100948.


RNA Sequencing and Spatial Transcriptomics in Traumatic Spinal Cord Injury (Review).

Chelyshev Y, Ermolin I Sovrem Tekhnologii Med. 2025; 15(6):75-86.

PMID: 39944372 PMC: 11811828. DOI: 10.17691/stm2023.15.6.08.


Efficient gene delivery admitted by small metabolites specifically targeting astrocytes in the mouse brain.

Zhou H, Dai J, Li D, Wang L, Ye M, Hu X Mol Ther. 2025; 33(3):1166-1179.

PMID: 39799395 PMC: 11897751. DOI: 10.1016/j.ymthe.2025.01.006.


Dysregulation of astrocytic Aquaporin-1 in the brains of oldest-old rhesus macaques: the NIA caloric restriction study.

Stayer-Wilburn O, Brown D, Woltjer R, Srinivasan S, Park B, Shultz P Geroscience. 2024; 47(1):781-793.

PMID: 39604627 PMC: 11872957. DOI: 10.1007/s11357-024-01431-6.


Spatial-temporal representation of the astroglial markers in the developing human cortex.

Kharlamova A, Krivova Y, Proshchina A, Godovalova O, Otlyga D, Andreeva E Brain Struct Funct. 2024; 229(9):2385-2403.

PMID: 39153086 DOI: 10.1007/s00429-024-02850-z.


References
1.
Zhou Q, Wang S, Anderson D . Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron. 2000; 25(2):331-43. DOI: 10.1016/s0896-6273(00)80898-3. View

2.
Olabarria M, Noristani H, Verkhratsky A, Rodriguez J . Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia. 2010; 58(7):831-8. DOI: 10.1002/glia.20967. View

3.
Allen N, Barres B . Neuroscience: Glia - more than just brain glue. Nature. 2009; 457(7230):675-7. DOI: 10.1038/457675a. View

4.
Hochstim C, Deneen B, Lukaszewicz A, Zhou Q, Anderson D . Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell. 2008; 133(3):510-22. PMC: 2394859. DOI: 10.1016/j.cell.2008.02.046. View

5.
Anthony T, Heintz N . The folate metabolic enzyme ALDH1L1 is restricted to the midline of the early CNS, suggesting a role in human neural tube defects. J Comp Neurol. 2006; 500(2):368-83. DOI: 10.1002/cne.21179. View